NCT00784849View on ClinicalTrials.gov

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

Methylene blue

1 mC1

Trial Locations (2)

70112

LSU Interim Hospital, New Orleans

70506

University Medical Center, Lafayette

All Listed Sponsors
lead

Louisiana State University Health Sciences Center in New Orleans

OTHER

NCT00784849 - Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) | Biotech Hunter | Biotech Hunter